Skip to content

Marketstatics

Menu
  • Home
  • About Us
  • Contact Us
Menu

Hyperimm Pertussis Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Hyperimm Pertussis Market Size and Forecast The global market for pertussis treatments and prevention, which includes hyperimmune globulin therapies (Hyperimm Pertussis) and vaccines, is expected to grow from USD 3.92 billion in…

SCIG for MG Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

SCIG for MG Market Size and Forecast The market for Subcutaneous Immunoglobulin (SCIG) specifically for Myasthenia Gravis (MG) is a rapidly growing niche within the broader immunoglobulin and MG treatment sectors. While…

IVIG for Guillain Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

IVIG for Guillain-BarrĂ© Syndrome Market Size and Forecast The market for Intravenous Immunoglobulin (IVIG) used in Guillain-BarrĂ© Syndrome (GBS) is a significant segment of the broader GBS therapeutics and IVIG markets. IVIG…

Entero Pleconaril Peds Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Entero/Pleconaril Peds Market Size and Forecast The market for Enterovirus (EV) treatments in pediatric populations, specifically concerning pleconaril, is niche and driven by outbreak potential and unmet medical need in severe cases…

VZV Zostavax Legacy Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

VZV Zostavax Legacy Market Size and Forecast The Varicella Zoster Virus (VZV) Zostavax Legacy market primarily refers to the residual revenue and usage of the Zostavax vaccine following its discontinuation in major…

HSV Abreva Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

HSV & Abreva Market Size and Forecast The overall Herpes Simplex Virus (HSV) treatment market, which includes over-the-counter (OTC) products like Abreva, was estimated at USD 2.47 billion in 2023. Abreva (docosanol…

Muco Ampho B Oral Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Muco Ampho B Oral Market Size and Forecast The Amphotericin B (AmB) market as a whole is substantial, estimated at approximately USD 220 million in 2022 and forecasted to reach USD 300…

Cand Diflucan Generics Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Fluconazole (Diflucan) Generics Market Size and Forecast The Fluconazole generics market, leveraging the off-patent status of the antifungal drug Diflucan, forms a significant segment within the broader anti-infectives and antifungal drugs sector….

Asper Noxafil Suspension Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Asper Noxafil Suspension Market Size and Forecast The market for Noxafil (Posaconazole) Suspension and its generic equivalents is positioned within the broader antifungal drug market, specifically targeting the prophylaxis and treatment of…

Cerv Zejula Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Zejula (Niraparib) Market Size and Forecast Zejula (niraparib) is a critical component of the PARP inhibitor class within the oncology market, primarily approved for the maintenance treatment of ovarian cancer. The drug…

Posts pagination

Previous 1 … 9 10 11 … 101 Next

Categories

  • Healthcare
  • Pharmaceutical
  • Uncategorized
©2025 Marketstatics | Design: Newspaperly WordPress Theme